Eugene A. Woods elected to Johnson & Johnson Board of Directors

JOHNSON & JOHNSON

Eugene A. Woods, CEO of Advocate Health, joined the board as a non-employee director effective Nov 30, 2023.
Mr. Woods will receive standard non-employee director compensation as described in 2023 Proxy Statement.
Advocate Health purchased ~$175M of Johnson & Johnson products in FY2022; JNJ paid <$1M for clinical trials.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Eugene A. Woods

Director

JNJ · JOHNSON & JOHNSON

Effective: 2023-11-30
Filed: December 5, 2023, 6:59 PM ET

On November 30, 2023, Johnson & Johnson (the “Company” or “Johnson & Johnson”) announced that Eugene A. Woods, MBA, MHA, was elected to the Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eugene A. Woods was elected as Director at JOHNSON & JOHNSON.

Action: elected
Role: Director

Exact text from the filing

On November 30, 2023, Johnson & Johnson (the “Company” or “Johnson & Johnson”) announced that Eugene A. Woods, MBA, MHA, was elected to the Board of Directors.

View on SEC.gov

JOHNSON & JOHNSON filing history →

Source: SEC EDGAR

accession 0000200406-23-000115

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.